DPT’s comprehensive archives of published articles provide insight into various aspects of pharmaceutical outsourcing, drug manufacturing, research and development and many other topics.
Formulation and Characterization of Nasal Sprays
Recently, specially-designed drug delivery devices have emerged that can administer sprays or powders to the olfactory region of the nose, thereby bypassing the blood-brain barrier and enabling delivery of the drug directly to the central nervous system. This article examines nasal spray formulation development parameters and excipients and their influence on key in vitro tests.
Building Flexibility, A New Business Model for a Volatile Industry
Working with a contract development and manufacturing organization (CDMO) with expertise in all the services you require ensures greater service uniformity, efficiency and collaboration throughout all processing stages. CDMOs can provide the processes, technology, specialized intelligence and rapid response to changing needs that can give you a competitive edge. They enable sponsors to rapidly scale drug development and manufacturing operations up or down and add specialized capabilities, accommodating flexible scheduling and volume spikes. As such, sponsors outsourcing effectively to a CDMO can move to a more variable cost structure while accessing more drug development and manufacturing expertise than if they kept everything in-house.
Strategies for Becoming a Preferred Provider
DPT senior vice president of sales & marketing, contributes to Pharmaceutical Technology’s article titled “Strategies for Becoming a Preferred Provider” and the growing emphasis throughout the pharmaceutical outsourcing arena on being a strategic, or preferred, provider. In the article Paul explains how contract manufacturing strategic partnerships allow a sponsor to gain greater supply chain visibility by more tightly integrating a CDMO into its operations.
Gaining Access to Global and Specialized Services
DPT vice president of marketing & project management contributes to an article highlighting the services DPT brings to the table and how the company is competing in the very competitive outsourcing environment. The breadth of services, from pre-formulation through the commercial cGMP manufacturing, make CDMOs ideal partners for specialty pharmaceutical companies.
Down the Track: Different Speeds with Multiple APIs
DPT vice president of research and development at DPT contributed to an article regarding the many options formulators and manufacturers have for modifying release profiles in multiple-API products. Dosage forms that contain more than one active pharmaceutical ingredient (API) can improve patient compliance and facilitate the treatment of certain diseases. Strategies to control the release of APIs in tablets and inhalable drugs include modifying the formulation, implementing specific coating technologies, and using techniques in particle-engineering.